Clinical Trial

Effect of Rg1-based Supplementation on Exercise Training-induced Stem Cell Recruitments and Skeletal Muscle Adaptation in Women Aged > 60

Study acronym: Senactiv
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study will provide novel insights into the role of bone marrow-derived stem cells in muscle adaptation to long-term exercise and advance our understanding of an Rg-1 based supplement-Senactiv® as a potential intervention for preventing sarcopenia and cognitive decline in older adults.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-09.
Trial Details
NCT Number NCT07703774
Lead Sponsor University of Taipei
Collaborators: Education University of Hong Kong
Conditions Myeloid Cell Infiltration
Enrollment 60 participants
Start Date 2026-08-02
Primary Completion 2029-01-02 (estimated)
Study Completion 2029-01-02 (estimated)
Updated on ClinicalTrials.gov 2026-07-22